Michael Greicius
Neurology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Michael Greicius’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A73822 · Current
Licensed to practise in California · since 2001 · expires 2029-01-31 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$7,433
Medicare paid this office $7,433 for 63 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 40 | $4,899 | $114 |
| Return visit (30+ min) | 15 | $1,131 | $75 |
Who their Medicare patients are
63 Original Medicare patients in 2024. Average age 78 · Women 46% · Health risk score 1.17. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: Dementia 75% · High blood pressure 59% · Depression 25% · Coronary heart disease 22% · Cancer 17%.
The office billed $17,401, Medicare allowed $10,791 and paid $7,433; for 71 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 63 | 71 | 78 | 1.17 | $17,401 | $7,433 |
| 2023 | 85 | 97 | 78 | 1.21 | $16,606 | $8,973 |
| 2022 | 108 | 124 | 77 | 1.22 | $22,478 | $10,146 |
| 2021 | 133 | 148 | 79 | 1.19 | $29,770 | $13,819 |
| 2020 | 120 | 143 | 78 | 1.30 | $37,547 | $8,802 |
| 2019 | 126 | 147 | 78 | 1.23 | $13,961 | $9,857 |
| 2018 | 135 | 160 | 77 | 1.13 | $18,746 | $11,933 |
| 2017 | 119 | 134 | 77 | 1.16 | $21,557 | $9,035 |
| 2016 | 156 | 188 | 78 | 1.21 | $37,636 | $12,443 |
| 2015 | 181 | 229 | 77 | 1.08 | $52,375 | $16,236 |
| 2014 | 161 | 240 | 77 | 1.35 | $57,506 | $17,223 |
| 2013 | 176 | 230 | 77 | 1.08 | $55,980 | $15,147 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 41 | $3,568 | $79 |
| Long return visit (40+ min) | 19 | $2,069 | $109 |
| New patient visit (45+ min) | 16 | $1,862 | $116 |
2022: 4 services
| Return visit (30+ min) | 47 | $3,302 | $66 |
| Long return visit (40+ min) | 22 | $2,358 | $98 |
| New patient visit (45+ min) | 18 | $1,925 | $107 |
| Short return visit (20+ min) | 17 | $839 | $49 |
2021: 5 services
| Return visit (30+ min) | 49 | $4,128 | $78 |
| Long return visit (40+ min) | 30 | $3,931 | $119 |
| New patient visit (60+ min) | 15 | $2,276 | $152 |
| New patient visit (45+ min) | 17 | $1,902 | $112 |
| Short return visit (20+ min) | 28 | $1,412 | $50 |
2020: 3 services
| New patient visit (45+ min) | 25 | $2,670 | $107 |
| Return visit (30+ min) | 33 | $2,320 | $59 |
| Short return visit (20+ min) | 43 | $1,725 | $39 |
2019: 4 services
| Short return visit (20+ min) | 64 | $3,118 | $43 |
| New patient visit (45+ min) | 28 | $2,887 | $103 |
| Return visit (30+ min) | 23 | $1,582 | $66 |
| Long return visit (40+ min) | 12 | $1,212 | $101 |
2018: 6 services
| New patient visit (60+ min) | 26 | $3,506 | $135 |
| New patient visit (45+ min) | 18 | $1,541 | $86 |
| Return visit (30+ min) | 25 | $1,472 | $57 |
| Long return visit (40+ min) | 14 | $1,397 | $100 |
| Short return visit (20+ min) | 35 | $1,216 | $33 |
| Short return visit (20+ min) | 15 | $691 | $46 |
2017: 4 services
| New patient visit (60+ min) | 21 | $2,937 | $140 |
| Short return visit (20+ min) | 66 | $2,690 | $37 |
| New patient visit (45+ min) | 15 | $1,660 | $111 |
| Return visit (30+ min) | 15 | $969 | $65 |
2016: 4 services
| Short return visit (20+ min) | 85 | $3,796 | $38 |
| New patient visit (60+ min) | 25 | $3,408 | $136 |
| New patient visit (45+ min) | 26 | $2,615 | $101 |
| Return visit (30+ min) | 22 | $1,441 | $66 |
2015: 4 services
| New patient visit (60+ min) | 31 | $4,593 | $148 |
| Short return visit (20+ min) | 83 | $3,968 | $39 |
| New patient visit (45+ min) | 35 | $3,705 | $106 |
| Return visit (30+ min) | 46 | $3,076 | $63 |
2014: 7 services
| Short return visit (20+ min) | 68 | $2,993 | $36 |
| Return visit (30+ min) | 43 | $2,819 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,338 | $180 |
| New patient visit (60+ min) | 17 | $2,336 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,985 | $64 |
| New patient visit (45+ min) | 13 | $1,488 | $114 |
| Long return visit (40+ min) | 14 | $1,283 | $92 |
2013: 3 services
| Short return visit (20+ min) | 109 | $4,870 | $36 |
| New patient visit (60+ min) | 33 | $4,500 | $136 |
| Long return visit (40+ min) | 19 | $1,788 | $94 |
Drugs they prescribed that Part D paid
$11,139
Pharmacies billed $11,139 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 227) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
227 generic and 0 brand-name prescriptions · $11,139 in drug cost · 38 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rivastigmine | 20 | $5,250 | $262 |
| Quetiapine | 38 | $2,986 | $79 |
| Donepezil | 70 | $1,325 | $19 |
| Carbidopa-Levodopa | 12 | $412 | $34 |
| Trazodone | 31 | $343 | $11 |
See all 8 drugs
| Rivastigmine | 20 | $5,250 | $262 |
| Quetiapine | 38 | $2,986 | $79 |
| Donepezil | 70 | $1,325 | $19 |
| Carbidopa-Levodopa | 12 | $412 | $34 |
| Trazodone | 31 | $343 | $11 |
| Sertraline | 25 | $289 | $12 |
| Phenytoin | 12 | $179 | $15 |
| Levetiracetam | 13 | $108 | $8 |
Year by year
| 2024 | 227 | 46 | 0% (0) | 0% | $11,139 |
| 2023 | 203 | 46 | 0% (0) | None | $9,818 |
| 2022 | 363 | 65 | 0% (0) | None | $8,961 |
| 2021 | 427 | 86 | 0% (0) | None | $13,118 |
| 2020 | 325 | 68 | 0% (0) | None | $14,371 |
| 2019 | 306 | 61 | 0% (0) | None | $12,037 |
| 2018 | 319 | 54 | 0% (0) | 4% | $15,244 |
| 2017 | 370 | 66 | 0% (0) | 7% | $27,548 |
| 2016 | 409 | 58 | 0% (0) | 7% | $25,791 |
| 2015 | 395 | 62 | 0% (0) | 8% | $20,001 |
| 2014 | 381 | 56 | 0% (0) | 7% | $11,487 |
| 2013 | 401 | 55 | 0% (0) | 12% | $16,928 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Rivastigmine | 14 | $5,068 | $362 |
| Donepezil | 86 | $1,408 | $16 |
| Quetiapine | 20 | $1,025 | $51 |
| Sertraline | 32 | $621 | $19 |
| Trazodone | 26 | $605 | $23 |
| Phenytoin | 11 | $434 | $39 |
2022: 4 drugs
| Donepezil | 175 | $3,153 | $18 |
| Quetiapine | 41 | $2,860 | $70 |
| Trazodone | 45 | $694 | $15 |
| Sertraline | 57 | $655 | $11 |
2021: 6 drugs
| Rivastigmine | 12 | $4,441 | $370 |
| Donepezil | 198 | $3,050 | $15 |
| Quetiapine | 71 | $2,074 | $29 |
| Trazodone | 51 | $479 | $9 |
| Sertraline | 45 | $404 | $9 |
| Mirtazapine | 11 | $322 | $29 |
2020: 6 drugs
| Donepezil | 182 | $2,191 | $12 |
| Quetiapine | 19 | $551 | $29 |
| Levetiracetam | 16 | $407 | $25 |
| Sertraline | 28 | $245 | $9 |
| Trazodone | 33 | $200 | $6 |
| Venlafaxine Hcl Er | 13 | $79 | $6 |
2019: 6 drugs
| Rivastigmine | 15 | $6,043 | $403 |
| Donepezil | 170 | $2,429 | $14 |
| Carbidopa-Levodopa | 20 | $1,020 | $51 |
| Quetiapine | 11 | $394 | $36 |
| Sertraline | 17 | $242 | $14 |
| Trazodone | 19 | $133 | $7 |
2018: 6 drugs
| Rivastigmine | 11 | $3,560 | $324 |
| Donepezil | 146 | $2,185 | $15 |
| Carbidopa-Levodopa | 15 | $1,008 | $67 |
| Quetiapine | 61 | $859 | $14 |
| Sertraline | 20 | $273 | $14 |
| Trazodone | 15 | $206 | $14 |
2017: 8 drugs
| Donepezil | 170 | $2,439 | $14 |
| Divalproex Sodium Er | 18 | $2,054 | $114 |
| Carbidopa-Levodopa | 19 | $652 | $34 |
| Quetiapine | 24 | $421 | $18 |
| Sertraline | 22 | $326 | $15 |
| Trazodone | 35 | $268 | $8 |
| Fluoxetine | 17 | $186 | $11 |
| Lorazepam | 14 | $173 | $12 |
2016: 10 drugs
| Rivastigmine | 13 | $8,712 | $670 |
| Exelon | 13 | $7,302 | $562 |
| Donepezil | 187 | $2,130 | $11 |
| Quetiapine | 32 | $1,764 | $55 |
| Divalproex Sodium Er | 20 | $1,294 | $65 |
| Carbidopa-Levodopa | 22 | $513 | $23 |
| Trazodone | 38 | $337 | $9 |
| Levetiracetam | 18 | $245 | $14 |
| Sertraline | 27 | $243 | $9 |
| Lorazepam | 16 | $240 | $15 |
2015: 8 drugs
| Exelon | 26 | $13,092 | $504 |
| Donepezil | 183 | $1,705 | $9 |
| Quetiapine | 42 | $549 | $13 |
| Sertraline | 33 | $341 | $10 |
| Trazodone | 48 | $321 | $7 |
| Lorazepam | 16 | $258 | $16 |
| Levetiracetam | 14 | $224 | $16 |
| Carbidopa-Levodopa | 14 | $220 | $16 |
2014: 8 drugs
| Exelon | 12 | $5,152 | $429 |
| Donepezil | 176 | $2,064 | $12 |
| Quetiapine | 39 | $1,236 | $32 |
| Venlafaxine Hcl Er | 43 | $1,117 | $26 |
| Levetiracetam | 21 | $324 | $15 |
| Trazodone | 41 | $228 | $6 |
| Sertraline | 24 | $153 | $6 |
| Lorazepam | 12 | $96 | $8 |
2013: 8 drugs
| Exelon | 14 | $6,311 | $451 |
| Donepezil | 188 | $3,252 | $17 |
| Quetiapine | 50 | $2,010 | $40 |
| Levetiracetam | 35 | $789 | $23 |
| Venlafaxine Hcl Er | 25 | $288 | $12 |
| Atorvastatin | 13 | $209 | $16 |
| Sertraline | 28 | $188 | $7 |
| Trazodone | 24 | $111 | $5 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1861443509
- Licence
- CA A73822California A73822: Current · expires 2029-01-31
- Trained
- Columbia University College of Physicians and Surgeons, 1996
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-15
- NPI last updated
- 2023-11-10
- NPI record certified
- 2023-11-10
This is when the NPI record was last certified, not a medical board exam.